Introduction to Ocular Manifestations in MPA

Microscopic polyangiitis (MPA) is a systemic small-vessel vasculitis that primarily targets the kidneys and lungs. While ocular involvement occurs in approximately 7% to 15% of patients, it usually affects the anterior segment, causing episcleritis or scleritis. However, choroidal ischemia in MPA represents an extremely rare and severe posterior segment manifestation. This condition poses a significant threat to vision if clinicians do not recognize it promptly. Recent clinical reports highlight that this ischemic process can occur alongside severe crescentic glomerulonephritis.

Clinical Presentation and Diagnostic Challenges

Diagnosis often begins with systemic symptoms. For instance, a 53-year-old woman recently presented with acute kidney injury and p-ANCA positivity. Biopsy confirmed pauci-immune crescentic glomerulonephritis. Despite starting aggressive treatment with pulse steroids and plasma exchange, she developed sudden bilateral visual loss ten days later. Interestingly, a standard fundus examination might show preserved retinal vasculature without obvious hemorrhages. This lack of visible retinal damage often delays the diagnosis of underlying choroidal perfusion issues.

Identifying Choroidal Ischemia in MPA via Angiography

Fluorescein angiography (FFA) remains the gold standard for detecting these rare ocular changes. In confirmed cases, FFA demonstrates normal retinal vessel filling but reveals diffuse, patchy background hypofluorescence. These patches usually appear at the posterior pole, indicating significant choroidal perfusion impairment. Consequently, clinicians must maintain a high index of suspicion when a patient with systemic vasculitis reports sudden vision changes. Furthermore, early imaging can differentiate this from other causes of vision loss, such as hypertensive retinopathy or optic neuropathy.

Effective Management and Outcomes

The management of ocular ischemia in the context of ANCA-associated vasculitis requires intensive immunosuppression. Treatment protocols typically include high-dose corticosteroids, cyclophosphamide, and potentially plasma exchange. Notably, continuing aggressive therapy often leads to complete visual recovery even after profound loss. Early intervention prevents the transition from reversible ischemia to permanent chorioretinal atrophy. Therefore, a multidisciplinary approach involving nephrologists, rheumatologists, and ophthalmologists is essential for optimizing both renal and visual outcomes.

Frequently Asked Questions

How common is vision loss in microscopic polyangiitis?

Ocular involvement occurs in a minority of MPA cases, and posterior segment ischemia is exceptionally rare. Most eye-related symptoms in ANCA vasculitis involve the anterior segment, such as scleritis or conjunctivitis.

What role does FFA play in diagnosing choroidal ischemia?

Fluorescein angiography is crucial because it can detect perfusion deficits in the choroid that are not visible during a standard bedside fundus examination. It identifies patchy hypofluorescence characteristic of vascular impairment.

Can vision loss from choroidal ischemia be reversed?

Yes, if diagnosed and treated rapidly with potent immunosuppressive agents like steroids and cyclophosphamide, the ischemia can be reversed, leading to a complete restoration of visual acuity.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Always seek the advice of a qualified healthcare provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.

References

1. İçaçan G et al. Reversible choroidal ischemia as a rare sight-threatening manifestation of microscopic polyangiitis presenting with crescentic glomerulonephritis. BMC Nephrol. 2026 Apr 02. doi: 10.1186/s12882-026-04828-x. PMID: 41928069.

2. Schmidt J, Pulido JS, Matteson EL. Ocular manifestations of systemic disease: antineutrophil cytoplasmic antibody-associated vasculitis. Curr Opin Ophthalmol. 2011;22(6):489–495. doi: 10.1097/ICU.0b013e32834bdfe2.

3. Hara A, Ohta S, Takata M, et al. Microscopic polyangiitis with ocular manifestations as the initial presenting sign. Am J Med Sci. 2007;334(4):308–310. doi: 10.1097/MAJ.0b013e3180a5e8c6.